Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gastric Neuroendocrine Tumor With Pancreatic Acinar Cell Differentiation in the Background of Atrophic Gastritis: A Possible Variant of Type 1 ECL-Cell NET-A Case Report. | Pathol Int | 2025 | 40326685 | PubTator, text mining | PubMed |
| Placental transcriptome reveals the placental brain axis genes and pathways of gestational diabetes mellitus (GDM) affecting offspring neurodevelopment. | Int J Dev Biol | 2025 | 40298873 | PubTator, text mining | PubMed |
| A comparative exploration of monoamine neurotransmitter transport disorders: mechanisms, clinical manifestations, and therapeutic approaches. | J Med Life | 2025 | 40291937 | PubTator, text mining | PubMed |
| Unique and overlapping mechanisms of valbenazine, deutetrabenazine, and vitamin E for tardive dyskinesia. | Schizophrenia (Heidelb) | 2025 | 40268947 | PubTator, text mining | PubMed |
| Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer. | Cancer Cell Int | 2025 | 40264196 | PubTator, text mining | PubMed |
| Diagnosis and management of tardive dyskinesia: from research to clinical practice. | Riv Psichiatr | 2025 | 40242923 | PubTator, text mining | PubMed |
| Impact of Intertarget Distances on Single-Isocenter Radiotherapy Plans with jaw-Tracking and jaw-Fixed Techniques for Vertebral Metastases. | Technol Cancer Res Treat | 2025 | 40211791 | PubTator, text mining | PubMed |
| Characterization of the Molecular Mechanisms Underlying Lurasidone-Induced Acute Manic Episodes in Bipolar Depression: A Network Pharmacology and Molecular Docking Approach. | CNS Neurosci Ther | 2025 | 40202273 | PubTator, text mining | PubMed |
| Multiparametric analysis based on 18F-AV133 PET/MR imaging for clinical application in Parkinson's disease. | Eur J Radiol | 2025 | 40194470 | PubTator, text mining | PubMed |
| Prodrug Approach as a Strategy to Enhance Drug Permeability. | Pharmaceuticals (Basel) | 2025 | 40143076 | PubTator, text mining | PubMed |
| Unveiling the potential abuse liability of α-D2PV: A novel α-carbon phenyl-substituted synthetic cathinone. | Neuropharmacology | 2025 | 40118207 | PubTator, text mining | PubMed |
| Application of separation and configuration identification of the four tetrabenazine stereoisomers in determining their pharmacokinetics. | Anal Bioanal Chem | 2025 | 40055199 | PubTator, text mining | PubMed |
| Baicalin restores dopamine homeostasis in the ADHD model by regulating DAT-VMAT2 transport imbalance through activation of the Nrf2/Keap-1/HO-1 pathway. | Free Radic Biol Med | 2025 | 40023299 | PubTator, text mining | PubMed |
| Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder. | Biomolecules | 2025 | 40001609 | PubTator, text mining | PubMed |
| Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database. | BMC Pharmacol Toxicol | 2025 | 39985106 | PubTator, text mining | PubMed |
| Evidence for low affinity of GABA at the vesicular monoamine transporter VMAT2 - Implications for transmitter co-release from dopamine neurons. | Neuropharmacology | 2025 | 39961377 | PubTator, text mining | PubMed |
| A Brief Summary of PET Imaging of Dopaminergic System. | World J Nucl Med | 2025 | 39959144 | PubTator, text mining | PubMed |
| Attenuated neurotoxicity after repeated methamphetamine binges linked to dopamine transporter (DAT) decline. | Neurobiol Dis | 2025 | 39947439 | PubTator, text mining | PubMed |
| Advanced Neuronal Modulation with Semiconducting Graphitic Carbon Nitride: Insights from In Vitro, In Vivo, and In Silico Studies. | ACS Appl Mater Interfaces | 2025 | 39903816 | PubTator, text mining | PubMed |
| Structural insights into substrate transport and drug inhibition of the human vesicular monoamine transporter 2 (VMAT2). | FEBS J | 2025 | 39887614 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=6